Items where Author is "Vadakekolathu, J"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 17.

Journal article

AL-JUBOORI, S.I.K., VADAKEKOLATHU, J., IDRI, S., WAGNER, S., ZAFEIRIS, D., PEARSON, J.R.D., ALMSHAYAKHCHI, R., CARAGLIA, M., DESIDERIO, V., MILES, A.K., BOOCOCK, D.J., BALL, G.R. and REGAD, T., 2019. PYK2 promotes HER2-positive breast cancer invasion. Journal of Experimental & Clinical Cancer Research, 38: 210. ISSN 1756-9966

WAGNER, S., VADAKEKOLATHU, J., TASIAN, S.K., ALTMANN, H., BORNHÄUSER, M., POCKLEY, A.G., BALL, G.R. and RUTELLA, S., 2019. A parsimonious 3-gene signature predicts clinical outcomes in an acute myeloid leukemia multicohort study. Blood Advances, 3 (8), pp. 1330-1346. ISSN 2473-9529

RUTELLA, S., CHURCH, S.E., VADAKEKOLATHU, J., VIBOCH, E., SULLIVAN, A.H., HOOD, T., WARREN, S.E., CESANO, A., LA MOTTE-MOHS, R., MUTH, J., LELIÈVRE, H., LOWENBERG, B., DIPERSIO, J.F. and DAVIDSON-MONCADA, J.K., 2018. Adaptive immune gene signatures correlate with response to flotetuzumab, a CD123 × CD3 bispecific Dart® molecule, in patients with relapsed/refractory acute myeloid leukemia. Blood, 132 (S1): 444. ISSN 0006-4971

UY, G.L., RETTIG, M.P., VEY, N., GODWIN, J., FOSTER, M.C., RIZZIERI, D.A., ARELLANO, M.L., TOPP, M.S., HULS, G., JONGEN-LAVRENCIC, M., MARTINELLI, G., PAOLINI, S., CICERI, F., CARRABBA, M.G., SWEET, K.L., RAVANDI, F., CHURCH, S.E., VADAKEKOLATHU, J., RUTELLA, S., SUN, J., YANG, K., BAUGHMAN, J., CURTIS, T., TIMMENY, E., CALI, K., TRAN, K., MUTH, J., LA MOTTE-MOHS, R., POIROT, C., PALLIS, A., CESANO, A., BONVINI, E., WIGGINGTON, J., LOWENBERG, B., DAVIDSON-MONCADA, J.K. and DIPERSIO, J.F., 2018. Phase 1 cohort expansion of flotetuzumab, a CD123×CD3 bispecific Dart® protein in patients with relapsed/refractory acute myeloid leukemia (AML). Blood, 132 (S1): 764. ISSN 0006-4971

FOULDS, G.A., VADAKEKOLATHU, J., ABDEL-FATAH, T.M.A., NAGARAJAN, D., REEDER, S., JOHNSON, C., HOOD, S., MOSELEY, P.M., CHAN, S.Y.T., POCKLEY, A.G., RUTELLA, S. and MCARDLE, S.E.B., 2018. Immune-phenotyping and transcriptomic profiling of peripheral blood mononuclear cells from patients with breast cancer: identification of a 3 gene signature which predicts relapse of triple negative breast cancer. Frontiers in Immunology, 9: 2028. ISSN 1664-3224

VADAKEKOLATHU, J., FOULDS, G.A., PATEL, T., REEDER, S., POCKLEY, A.G., TASIAN, S.K. and RUTELLA, S., 2018. Immune gene expression profiling identifies predictors of relapse in childhood acute myeloid leukemia. Cancer Immunology Research, 6 (9 Supp): B62. ISSN 2326-6066

VADAKEKOLATHU, J., AL-JUBOORI, S.I.K., JOHNSON, C., SCHNEIDER, A., BUCZEK, M.E., DI BIASE, A., POCKLEY, A.G., BALL, G.R., POWE, D.G. and REGAD, T., 2018. MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer. Cell Death & Disease, 9: 344. ISSN 2041-4889

RUTELLA, S., VADAKEKOLATHU, J., ALTMANN, H., PATEL, T., REEDER, S., LIANG, Y., SCHMITZ, M., HOOD, T., DANAHER, P., WARREN, S., CESANO, A., BEECHEM, J.M., POCKLEY, A.G., TASIAN, S.K. and BORNHÄUSER, M., 2018. Capturing the complexity of the immune microenvironment of acute myeloid leukemia with 3D biology technology. Journal of Clinical Oncology, 36 (5 supp), p. 50. ISSN 0732-183X

BALAHMAR, R.M., BOOCOCK, D.J., COVENEY, C., RAY, S., VADAKEKOLATHU, J., REGAD, T., ALI, S. and SIVASUBRAMANIAM, S., 2018. Identification and characterisation of NANOG+/OCT-4high/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines. Oncotarget. ISSN 1949-2553

VADAKEKOLATHU, J., PATEL, T., REEDER, S., SCHAARSCHMIDT, H., SCHMITZ, M., BORNHÄUSER, M., WARREN, S.E., HOOD, T., DANAHER, P., CESANO, A., BEECHEM, J.M., POCKLEY, A.G., TASIAN, S.K. and RUTELLA, S., 2017. Immune gene expression profiling in children and adults with acute myeloid leukemia identifies distinct phenotypic patterns. Blood, 130 (Supp 1), 3942A. ISSN 0006-4971

VADAKEKOLATHU, J., MEREDITH, R., ROSS, P.M., WAGNER, S., REEDER, S., DEMIRKAN, G., KUHAR, J.R., BALL, G.R., POCKLEY, A.G. and RUTELLA, S., 2017. Interferon-γ induces distinct mRNA and protein profiles in acute and chronic myeloid leukemia. Blood, 130 (Supp 1), 3945A. ISSN 0006-4971

HARNER-FOREMAN, N., VADAKEKOLATHU, J., LAVERSIN, S.A., MATHIEU, M.G., REEDER, S., POCKLEY, A.G., REES, R.C. and BOOCOCK, D.J., 2017. A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics. Scientific Reports, 7, p. 40633. ISSN 2045-2322

ZAFEIRIS, D., VADAKEKOLATHU, J., WAGNER, S., POCKLEY, A.G., BALL, G.R. and RUTELLA, S., 2017. Discovery and application of immune biomarkers for hematological malignancies. Expert Review of Molecular Diagnostics, 17 (11), pp. 983-1000. ISSN 1473-7159

VADAKEKOLATHU, J. and RUTELLA, S., 2017. T-Cell manipulation strategies to prevent graft-versus-host disease in haploidentical stem cell transplantation. Biomedicines, 5 (2), p. 33. ISSN 2227-9059

SAIF, J.M.S., VADAKEKOLATHU, J., RANE, S.S., MCDONALD, D., AHMAD, M., MATHIEU, M., POCKLEY, A.G., DURRANT, L., METHERINGHAM, R., REES, R.C. and MCARDLE, S.E.B., 2014. Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice. European Journal of Immunology, 44 (4), pp. 994-1004. ISSN 0014-2980

Chapter in book

VADAKEKOLATHU, J., MILES, A.K., BOOCOCK, D.J. and MCARDLE, S.E.B., 2014. Identification of tumor antigens for clinical evaluation. In: Tumor immunology and immunotherapy. Oxford: Oxford University Press, pp. 127-129. ISBN 9780199676866

Thesis

VADAKEKOLATHU, J., 2013. Characterisation of high and low avidity peptide specific CD8+ T cells using immunologic, transcriptomic and proteomic tools. PhD, Nottingham Trent University.

This list was generated on Mon Dec 9 21:18:00 2019 UTC.